Skip to content

Clinical trials

Completed Phase 1 Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Phase 1 Status: Completed Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20043
20062
20091
20121
20151
20183
20191
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Regeneron Pharmaceuticals2
Abramson Cancer Center at Penn Medicine1
Alliance for Clinical Trials in Oncology1
Beijing Health Guard Biotechnology, Inc1
Case Comprehensive Cancer Center1
Gene Surgery LLC1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms22
Vulvar Neoplasms22
Vaginal Neoplasms18
Endometrial Neoplasms12
Anus Neoplasms11
Carcinoma, Ovarian Epithelial11
Fallopian Tube Neoplasms11
Penile Neoplasms9
Breast Neoplasms8
Carcinoma, Hepatocellular8

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.